RareDiseasesNews.net

Rare diseases Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Amyloidosis"

A study has shown that Etanercept ( Embrel ) reduces the frequency and severity of symptoms of TNF receptor-associated periodic syndrome ( TRAPS ), a rare inherited condition characterized by recurren ...


A study led by researchers from the Amyloidosis Center at Boston University School of Medicine ( BUSM ) and Boston Medical Center ( BMC ) has demonstrated that Diflunisal, a generic anti-inflammatory ...


Transthyretin ( TTR ) amyloidosis is a progressive systemic disorder caused by misfolded TTR monomers that cumulatively deposit in the heart and systemically as amyloid. A phase 2 open-label trial ...


The role of induction therapy prior to autologous stem cell transplant ( ASCT ) in immunoglobulin light chain ( AL ) amyloidosis remains controversial. Data on the prognostic impact of response to i ...


HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated ( ATTR ) amyloidosis, met its primary and both secondary endpoints ...


Full positive results from the HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated ( ATTR ) amyloidosis, which met its ...